Cafepharma Today

June 20 2025 - Gene therapy faces fresh uncertainty as two more top FDA officials depart
Gene therapy faces fresh uncertainty as two more top FDA officials depart
Eli Lilly (LLY) sees strong demand for Mounjaro in India
A longer ‘winter’: Public funding slowdown heightens pressure on biotech startups
Is DTC pharma advertising coming to an end?
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Zimmer: We're not pushing the device tax down the line
Mass Device
Tuesday, January 8, 2013 - 11:13pm
tags:
Zimmer, device tax, devices
Interview: Medtronic CEO Ishrak on the road ahead
Mass Device
Tuesday, January 8, 2013 - 11:12pm
tags:
Medtronic, CEO
CardioKinetix targets FDA approval with heart-failure device trial
FierceMedicalDevice
Tuesday, January 8, 2013 - 11:09pm
tags:
CardioKinetix, FDA, heart, devices
J&J back in court over DePuy hip implants
FierceMedicalDevice
Tuesday, January 8, 2013 - 11:08pm
tags:
J&J, Johnson & Johnson, DePuy, hip, implants, legal
Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against St. Jude Medical, Inc.
Yahoo/BusinessWire
Tuesday, January 8, 2013 - 11:05pm
tags:
lawsuit, legal, St. Jude Medical
UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Abiomed, Inc. of Class Action Lawsuit and the Deadline of January 15, 2013 to Seek a Lead Plaintiff Position
Yahoo/MarketWire
Tuesday, January 8, 2013 - 11:04pm
tags:
Abiomed, lawsuit, investment
Law Office of Brodsky & Smith, LLC Announces Investigation of Epocrates, Inc.
Yahoo/BusinessWire
Tuesday, January 8, 2013 - 11:02pm
tags:
legal, investigation, Epocrates
Cantel Medical's Mar Cor Purification Subsidiary Acquires Eagle Pure Water Systems, Inc.
Yahoo/PRNewswire
Tuesday, January 8, 2013 - 10:50pm
tags:
Cantel Medical, M&A, devices
Thoratec Announces FDA Approval To Commence REVIVE-IT Study Utilizing HeartMate II®
Yahoo/PRNewswire
Tuesday, January 8, 2013 - 10:50pm
tags:
Thoratec, FDA, HeartMate II
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Young Innovations, Inc. in Connection the Sale of the Company to Linden Capital Partners
Yahoo/BusinessWire
Tuesday, January 8, 2013 - 10:49pm
tags:
shareholders, investigation, legal, Young Innovations
Teleflex Signs New Agreements with Premier for Surgical Instruments
Yahoo/BusinessWire
Tuesday, January 8, 2013 - 10:45pm
tags:
Teleflex Medical, Premier, surgical, devices
BIOLASE Completes Sale of Last WaterLase MD Turbo Laser Systems Repurchased From Schein
Yahoo/MarketWire
Tuesday, January 8, 2013 - 10:45pm
tags:
BIOLASE IMAGING, laser, Schein, M&A, devices
Baxter Announces Phase III Data Evaluating Prophylaxis Treatment of FEIBA NF for Hemophilia Patients with Inhibitors
Yahoo/BusinessWire
Tuesday, January 8, 2013 - 10:43pm
tags:
Baxter International, treatment, hemophilia, patient, Device
What Is Keryx Biopharmaceuticals And Why Does It Matter?
Seeking Alpha
Tuesday, January 8, 2013 - 12:10pm
tags:
Keryx, Zerenex, hyperphosphatemia
Is Teva Investing Enough in Its Branded Products?
Motley Fool
Tuesday, January 8, 2013 - 12:10pm
tags:
Teva, Merck, Pfizer
Bill Gates Invests In Cancer DNA Sequencing Firm
Forbes
Tuesday, January 8, 2013 - 10:39am
tags:
Bill Gates, DNA sequencing, Foundation Medicine
FDA designates GTx's enobosarm as Fast Track development program
Yahoo/Fly on the Wall
Tuesday, January 8, 2013 - 10:38am
tags:
FDA, GTx, enobosarm, fast track, non-small cell lung cancer
Regeneron reports Q4 Eylea U.S. net sales $276M
The Fly on the Wall
Tuesday, January 8, 2013 - 10:32am
tags:
Eylea, Regeneron, JPMHC 2013
Celgene Most Impressive On Day 1 of J.P. Morgan Healthcare Confab
TheStreet.com
Tuesday, January 8, 2013 - 10:31am
tags:
Celgene, JPMHC 2013
Amgen Agrees to Deal with Bind to Develop Cancer Drugs
Bloomberg
Tuesday, January 8, 2013 - 10:30am
tags:
Amgen, Bind Biosciences, cancer, Nanotechnoogy

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Stir Bars Can't Be Ignored
In the Pipeline
AI Effects on Drug Patents
In the Pipeline
Mirror Morphine
In the Pipeline
Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.